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Due to its abundance, easy retrieval, and plasticity characteristics, adipose-tissue-derived stromal cells (ATSCs) present unques-
tionable advantages over other adult-tissue-derived stem cells. Based on the in silico analysis of our previous data reporting the
ATSC-speciﬁc expression proﬁles, the present study attempted to clarify and validate at the functional level the expression of
the neurospeciﬁc genes expressed by ATSC both in vitro and in vivo. This allowed evidencing that ATSCs express neuro-speciﬁc
trophins, metabolic genes, and neuroprotective molecules. They were in fact able to induce neurite outgrowth in vitro,a l o n g
with tissue-speciﬁc commitment along the neural lineage and the expression of the TRKA neurotrophin receptor in vivo.O u r
observation adds useful information to recent evidence proposing these cells as a suitable tool for cell-based applications in
neuroregenerative medicine.
1.Introduction
Adipose-tissue-derived adult pluripotent cells, commonly
known as adipose tissue stromal cells (ATSCs) are mesenchy-
mal stem cells (MSCs) residing in the connective stroma of
adiposetissue.Theyrepresentavaluablesourceofadultstem
cells, being easily isolated from an abundant and accessible
tissue [1–3]. Their plasticity along with the ease of in vitro
culturing and propagation makes them the most used cell
type in a wide range of tissue regeneration applications [4–
7].
We have previously shown the ATSC-speciﬁc molecular
properties, by comparatively analyzing the geno-mewide
expression proﬁles of MSCs from diﬀerent adult tissues [3].
The study allowed indicating the main molecular features
which regulate the stemness maintenance of MSCs and a
more extensive plasticity of ATSC in vitro. The complete
result dataset of this previous study (available at the
GeneExpressionOmnibus(GEO)database,http://www.ncbi
.nlm.nih.gov/gds,accessionnumberGSE8954)alsoindicated
that ATSCs speciﬁcally express neurospeciﬁc genes.
The purpose of this study is to extract the biologically
signiﬁcantgenesfromthisdatasetandvalidatethefunctional
relevance of the neurotrophic genes expressed by ATSC both
in vitro and in vivo.
2.MaterialsandMethods
2.1. In Silico Biological Analysis of the Microarray Dataset. In
order to identify the candidate genes involved in the neu-
rotrophic properties of ATSCs, the gene list of ATSC-speciﬁc
genes obtained through the microarray-based gene proﬁling
of ATSC compared to bone-marrow-derived mesenchymal
cells (BMSCs) and ﬁbroblasts (http://www.ncbi.nlm.nih
.gov/gds, accession number GSE8954) [3] underwent an ad
hoc biological analysis, aimed at ﬁnding neurologically rele-
vant genes. For this purpose, the list of 441 genes speciﬁcally
upregulated in ATSC (P value <0.01), resulting from the
statisticalanalysis(see[3]forstatisticalmethodsusedindata
analysis), were categorized according to the “biological func-
tion” annotations implemented from the Gene Ontology2 Journal of Biomedicine and Biotechnology
Annotation (GOA) database (http://www.ebi.ac .uk/GOA/).
Speciﬁc neuroprotective, neurodevelopmental, and/or neu-
rotrophic functions were further studied using the “Gene
Reference Into Function” tool in GenBank (http://www.ncbi
.nlm.nih.gov/gene/about-generif).
2.2. Patients and Specimens. Adipose tissue (AT) specimens
were obtained by lipoaspiration from healthy volunteers
(mean age 40.2 ± 14.2 years) upon obtaining a written con-
sent. A skin biopsy was obtained from the retroauricular
region of an healthy male donor (aged 45) and served for
theisolationofhumandermalﬁbroblasts(HDF).Individuals
data were handled conﬁdentially and anonymously. All the
procedures employed in this study were approved by the
ethicalcommitteeoftheCatholicUniversityofRome(Rome,
Italy; number P552 (A.779)/CE2007).
2.3. Chemicals and Reagents. Cell culture media and sup-
plements were purchased from Lonza (Basel, Switzerland).
Enzymes, growth factors, and all other chemicals used in this
study were purchased from Sigma (Sigma-Aldrich, St Louis,
Mo,USA), unless otherwise speciﬁed.
2.4. ATSC Isolation and Culture. Mesenchymal stromal cells
were isolated in primary culture from the lipoaspirates, as
already described elsewhere [3]. Brieﬂy, AT was extensively
washed, mechanically fractionated, and digested using 0.1%
collagenase type VIII. The lysed tissue was then ﬁltered
through a 100μm mesh, and the cell suspension was cen-
trifuged. The cell pellet was then plated in T75 tissue
culture ﬂasks using Dulbecco’s Modiﬁed Eagle’s Medium
(DMEM), supplemented with 10% FBS, 100units/mL peni-
cillin, 100μg/mL streptomycin, and 0.2ng/mL ﬁbroblast
growth factor beta (bFGF). Cells were subcultured as pre-
viously described [3] and then used for in vitro and in
vivo experiments, as detailed in the following paragraphs.
ATSCs growth kinetics up to ﬁfteen culture passages and
their immunophenotype were assessed as already described
elsewhere [6].
2.5. HDF Isolation and Culture. Dermal ﬁbroblast were iso-
lated in primary culture from the skin biopsy and cultured as
previouslydescribed[8].Thesecellsservedasamesodermal-
derived diﬀerentiated controls to produce the conditioned
medium (HDF-CM) used in the in vitro experiments (see
following paragraphs).
3.In Vitro ExperimentalProcedures:
NeuralCellLineCulturesandTreatments
In order to assess the functional signiﬁcance of the neu-
rotrophic genes speciﬁcally expressed by ATSCs, LAN5 and
P C 1 2c e l l sw e r eu s e da sn e u r a lu n d i ﬀerentiated cell lines
for the in vitro experiments. These cell lines are commonly
employed as valuable models to study the neuronal diﬀeren-
tiation and degeneration processes in vitro [9–13].
3.1.Cell LinesandTreatments. Thehuman LAN-5 dopamin-
ergic cells were grown in Dulbecco’s modiﬁed Eagle medium
(DMEM) supplemented with 2mM glutamine, 40μg/mL
gentamicin,and10%heat-inactivatedfetalcalfserum(FCS),
according to standard protocols [13]. Cells were plated at
a1 0 4/cm2 seeding density in 24-well plates. The day after
plating,ATSCswereseededinthesamewellsusinga104/cm2
seeding density. In addition, separate wells of LAN5 cells
were cultured in presence of ATSC-conditioned medium
(ATSC-CM), which was obtained by ﬁltering through a
0.2μm cellulose acetate ﬁlter the supernatant medium of
subconﬂuent ATSC cultures. Thereafter, both LAN5-ATSC
cocultures and ATSC-CM-treated cells were grown for three
days without changing the culture medium.
The rat PC12 noradrenergic cell line was seeded at a
density of 5000cells/cm2 in RPMI 1640 medium containing
5%fetalcalfserumand10% horseserumandgrowntill 80%
conﬂuence, according to standard protocols [12]. Between
the third and the fourth culture passage, cells were plated in
24-well plates, using a 104/cm2 seeding density. The day after
plating, the PC12 culture medium was replaced by either
ATSC-CM or HDF-CM. LAN5 and PC12 cells in standard
culture medium served as controls in the experiments. As
PC12 cells are known to diﬀerentiate along a functional
neuronal phenotype upon NGF treatment, cells primed
with 50ng/mL of NGFβ were used as positive control of
diﬀerentiation [9]. Cellular morphology was evaluated by an
invertoscope up to four days of culture.
4.In Vivo ExperimentalProcedures:
Neonatal Rat BrainATSCInoculation
4.1. Adenoviral-Mediated Cell Transduction. In order to
make ATSC recognizable in living tissues, cells were trans-
fected using a defective adenoviral vector carrying the
enhanced green ﬂuorescent protein (AdEGFP) as a reporter
gene. AdEGFP stocks were kindly provided by the Vector
Core Facility of the University of Pittsburgh (Pa, USA). Cells
were plated at a 104/cm2 seeding density and treated with
AdEGFP using a multiplicity of infection (MOI) of 100
plaque-forming units (pfu)/cell. The eﬃciency of cell trans-
duction was assessed observing ﬂuorescent cells 48 hours
laterusinganinvertoscopeequippedwithaﬂuorescentlamp.
EGFP-expressing cells were then inoculated in neonatal rats,
as further described.
4.2. Cell Transplantation. Human ATSCs were transduced
with Ad.eGFP 48 hours prior to in vivo transplantation. The
surgery was performed on neonatal rats at postnatal day 1
(P1), after the induction of deep anesthesia by hypothermia.
A small parietal hole was made into the skull above the
frontal cortex, and cells were slowly injected into the lateral
ventricle (1mm posterior to the bregma, 1mm lateral to the
midline, and 2–2.5mm ventral to the pial surface) using a
glass micropipette coupled to a Hamilton microsyringe. For
each animal treated, 5 × 104 ATSCs suspended in 1μLo f
Puck’s saline A (Invitrogen, Carlsbad, Ca) were used. Sham-
operated animals were injected with the same volume ofJournal of Biomedicine and Biotechnology 3
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Figure 1: Hierarchical clustering of microarray data. The dendrogram shows all the 441 genes diﬀerentially expressed in ATSC (selected by
t-test, P value 0.01) resulting from the statistical analysis [3]. Each row represents a single gene, while cell types are grouped in columns.
The colored representation of gene expression is shown according to the scale on the right side of the ﬁgure. BMSC: bone-marrow-derived
stromal cells; MRC5: human lung ﬁbroblast cell line. See [3]f o rd e t a i l s .
saline solution. Following treatment, the skin was rapidly
sutured, the pups were warmed under a lamp and returned
to the dame. All animal protocols used have been approved
by the Animal Experimentation Committee of the Catholic
University of Rome.
4.3. Tissue Processing. The animals were sacriﬁced 7 and 15
days after injection (n = 6f o re a c hg r o u po fA T S Ct r e a t e d
rats, and n = 3 for each group of sham-treated animals).
Under deep anaesthesia (ketamine/diazepam 1:1 i.p.), they
were perfused through the aorta with 100mL of saline
solution, followed by 100mL of 0.01M, pH 7.4 PBS, and
4% paraformaldehyde. Thirty minutes after perfusion, the
brains were removed from the skull, postﬁxed in 4% PBS
paraformaldehyde for 2h and immersed in 30% sucrose.
Serial 40μm thick coronal sections were cut on a freezing
m i c r o t o m e .T h eﬁ r s ts e r i e so fs e c t i o n sw a sm o u n t e di n
Vectashield (Vector, UK) for ﬂuorescent evaluation of eGFP-
expressing cells. Other series of adjacent sections were
processed for immunohistochemistry.
4.4. Immunohistochemistry. Anti-GFAP (polyclonal, Dako,
Glostrup, Denmark, 1:1000 overnight at 4◦C), -Doublecort-
in (policlonal, Chemicon, Temecula, Ca, 1:3000, overnight
at 4◦C), -NeuN (monoclonal, Chemicon, Temecula, Ca,
1:500,48hat4◦C),-O4(monoclonal,Chemicon,Temecula,
CA, 1:500, overnight at 4◦C), and -TrKA (Santa Cruz
Biotechnology, Heidelberg, Germany, 1:1000 overnight at
4◦C)wererevealedusingcyanineﬂuorochromes-labeledsec-
ondary antibodies (donkey anti-mouse Cy3 or donkey anti-
rabbit Cy3, Jackson Immunoresearch Laboratories, West
Grove, Pa, 1: 400) following incubation for 1 hour at RT.
Sections were mounted in Vectashield for ﬂuorescent visu-
alisation of labeled cells. Controls were prepared by omitting
the primary antibodies.
The colocalization of eGFP with the above-mentioned
markers was examined with a Zeiss LSM 510 confocal laser
scanning microscopy system.
5. Results
5.1. ATSCs Express Neurospeciﬁc Genes. Data extracted from
previously published microarray data showed the selective
upregulation of 441 genes (P<0.01) in ATSC compared to
BMSC and human ﬁbroblast MRC5 cells (Figure 1). The in
silico biological analysis of the microarray data (GEO dataset
number GSE8954) allowed to identify a short list of bio-
logically relevant genes, involved in neuroprotection, neural
developmental processes, and neurotrophic functions (see
Table 1). In particular, this 12-transcript list included genes,
namely, nerve growth factor beta (NGFB), neuropilin 14 Journal of Biomedicine and Biotechnology
(a) (b)
∗
∗
∗
∗
∗
(c)
∗ ∗
(d)
(e) (f) (g) (h)
Figure 2: In vitro neurotrophic eﬀects of ATSC. LAN-5 human neuroblasts and PC12 rat cells were cultured either ATSC-conditioned
medium or co-cultured with ATSC and morphological modiﬁcations were monitored over time: (a) LAN5 in standard culture medium;
(b) LAN5 cultured in ATSC-CM for 72 hours; (c) and (d) LAN-5 co-cultured with ATSC using a cell density of 104 cell/cm2 for both cell
populations; (e) PC12 in standard culture medium; (f) PC12 cultured in ATSC-CM for 4 days; (g) PC12 cultured in βNGF 100ng/mL for 4
days; (h) PC12 cultured in HDF-conditioned medium for 4 days. Arrows show evidence of neurite outgrowth; asterisk (∗) indicate ATSC in
culture. Scale bar 100μmi na l lp a n e l se x c e p tf o rp a n e ld = 10μm.
10µm
Figure 3: Eﬃcient adenoviral-mediated transduction of ATSC.
ATSCs were transfected with 100pfu/cell of AdEGFP and ﬂuores-
cent cells were observedafter 48hours:nearly 80%cells wereEGFP-
positive as shown in the ﬁgure.
(NRP1), and GTP cyclohydrolase 1 (GCH1), encoding sol-
uble neurotrophins which are known to mediate neuronal
growth, diﬀerentiation, migration, and neuroprotection [9,
14, 15]. The neuronal cadherin CDH2 belongs to the major
transmembranar signalling complex cadherin/catenin that
plays a key role in neuronal processes during early devel-
opment. It is activated during neural circuit formation and
maturation to mediate axonal outgrowth and arborisation
[16, 17]. Moreover, nearly all genes in the list are implicated
in developmental processes within the nervous system,
such as neurogenesis, neuron diﬀerentiation, axonogenesis,
axon guidance, nerve growth, and glia diﬀerentiation and
migration (Table 1). The phosphoribosyl pyrophosphate
synthetase 1 (PRPS1) and the phosphoglycerate mutase 1
(PGAM1) genes are implicated in metabolic pathways which
are essential in neuronal function and maintenance (see
function details and references in Table 1).
5.2. ATSCs Induce Neurite Outgrowth in PC12 and LAN5
Cells. In order to evaluate the eﬀects of the supposed
neurotrophic properties of ATSC, the capability of inducing
visible changes in cell morphology of neural cells was ﬁrst
assessed in vitro. For this purpose, LAN5 cells were either
cultured in ATSC-CM or cocultured with human ATSC for
three days. Both cells cultured in ATSC-CM (Figure 2(b))
and those in coculture (Figures 2(c)-2(d)) displayed evident
changes in shape and morphology, compared to those grown
in standard culture medium (Figure 2(a)). The morpholog-
ical changes consisted in the formation and elongation of
neurite-like processes observed in discrete loci of the culture
plate. The outgrown neurites seemed to establish contacts
with both neural cells and ATSC in culture (Figure 2(d)).
In addition, the adrenergic PC12 cell line was cultured in
presenceofATSC-conditionedmedium(ATSC-CM)forfour
days. PC12 primed with βNGF and PC12 cultured in HDF-
CM was used as positive and negative neuro-diﬀerentiation
controls, respectively. The morphological analysis showed
the extensive outgrowth and extension of neurite-like struc-
tures in both βNGF- and ATSC-CM-treated cells exhibiting
essentiallyoverlappingfeatures(Figure 2(f)-2(g)),compared
to cells cultured in standard medium (Figure 2(e)). Cells
grown in HDF-CM showed clear morphological signs of
distress, becoming small-rounded vacuolized cells, with a
marked tendency to detach (Figure 2(h)).Journal of Biomedicine and Biotechnology 5
Table 1: Selected ATSC-speciﬁc upregulated genes involved in neurospeciﬁc functions (P<0.01).
Gene symbol Gene bank Gene name Neurospeciﬁc functions Process References
protection development trophism metabolism
SLC1A1 NM 004170.5 Solute carrier
family 1, member 1 +
Protection against
glutamate
neurotoxicity
[18]
CDH2 NM 001792.3
Cadherin 2, type 1,
N-cadherin
(neuronal)
+
Pre-to-
postsynaptic
adhesion neuronal
migration
Axonogenesis
synapse assembly
[19]
CELF2 NM 001025077.2
CUG triplet repeat,
RNA binding
protein 2
++
Motor neuron
survival splicing
control during
development
[7]
VLDLR NM 003383.3
Very low density
lipoprotein
receptor
++ +
Protection against
hypoxia and
glucose starvation
Nervous system
development lipid
uptake in neurons
and astrocytes
[20]
NRP1 NM 003873 Neuropilin 1 + + +
Cell survival axon
guidance
Migration and
invasion
[15]
NGFB NM 002506.2
Nerve growth
factor, beta
polypeptide
+
Neuron
diﬀerentiation
nerve growth
[9]
ENC1 NM 003633.2 Ectodermal-neural
cortex ++
Anti-apoptotic
nervous system
development
[21]
GCH1 NM 000161.2 GTP
cyclohydrolase 1 ++
Protection from
brain damaging
events secreted by
astrocyte
[14]
FGF2 NG 012449.1 Fibroblast growth
factor 2 ++ Neurogenesis
migration [22]
NDN NM 002487.2 Necdin homolog
(mouse) ++
Protects neuron
from oxidant stress
Neuron
development glial
cell migration
[23]
PRPS1 NM 002764.3
Phosphoribosyl
pyrophosphate
synthetase 1
++
Purine synthesis
nervous system
development
[24, 25]
PGAM1 NM 002629.2 Phosphoglycerate
mutase 1 (brain) ++
Regulation of
energy metabolism
neuroprotection
against Aß-toxicity
[26]
5.3. In Vivo Analysis of ATSC-Speciﬁc Neurotrophic Features.
The functional signiﬁcance of the ATSC-speciﬁc upregula-
tion of genes involved in the neural lineage has been further
investigated in vivo after transplantation of ATSCs in the
neonatal rat brain. ATSCs were eﬃciently transduced with
Ad.eGFP prior to in vivo transplantation (Figure 3).
Histological examination of ATSC-transplanted young
rats sacriﬁced 7 days after transplantation showed clusters
of eGFP-positive ATSCs, characterized by rounded mor-
phology, localized in the wall of the lateral ventricle, near
the needle tract, surrounded by GFAP positive astroglial
endings (Figure 4(a) A–C). In particular, based on the results6 Journal of Biomedicine and Biotechnology
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Figure 4:EngraftmentofhumanATSCswithinnewbornratbrain.(a)ConfocalmicroscopymicrographsshowingtheengraftmentofeGFP-
positive (green; A, D) ATSCs within newborn rat brain 1 week after cell infusion. ATSCs exhibit a round morphology (A, C), are surrounded
by GFAP-positive astrocytes (red; B, D), and express TRKA (red, B, D, arrows). (b) Engraftment and in vivo diﬀerentiation of human ATSCs
within newborn rat hippocampus 2 weeks after implantation. Confocal images of GFAP (red; A) or TRKA (red; D) immunolabeled eGFP
(green; B, E) expressing ATSCs. Engrafted cells express the astrocytic marker GFAP (yellow, C) and the TRKA receptor (yellow, F). Scale
bars: (a) A–C 120μm, (a) D–F 420μm, (b) A–C 80μm ,a n d( b )D – F6 0μm.Journal of Biomedicine and Biotechnology 7
observed in vitro, we assessed the expression of the anti-
NGF-β receptor, as to further investigate the signiﬁcance
of the NGF/TRKA signaling pathway. ATSCs exhibited
immunopositivity for the TRKA antibody 7 days after
transplantation (Figure 4(a) D–F). At this time point, no co-
localization with neuronal (Doublecortin, NeuN), astroglial
(GFAP), or oligodendroglial (O4) markers were observed
(not shown).
Histological examination of young rats sacriﬁced 15
days after transplantation conﬁrmed the survival of ATSCs
in the brain of injected animals. Grafted cells examined
at this time point were mainly localized within the brain
parenchyma, near the ventricular system and frequently in
the hippocampus. They showed a bipolar or multipolar
morphology with processes extending in various directions.
Interestingly, confocal microscopy examination revealed that
many of these eGFP- positive ATSCs coexpressed also the
astroglial marker GFAP (Figure 4(b) A–C), while no colocal-
ization between eGFAP and Doublecortin, NeuN, or O4 was
found (not shown). Virtually all engrafted ATSCs expressed
immunopositivity for anti-TRKA antibody (Figure 4(b) D–
F)). Sham-operated animals exhibited only a mild GFAP-
stained glial reaction around the needle tract (not shown).
6. Discussion
Diﬀerent evidences indicated that transplanted MSCs pro-
mote endogenous repair of neurologically damaged areas
and neural diﬀerentiation, via the release of soluble trophic
factors and cytokines [27].
In particular, recent studies indicated that ATSC culture
medium should contain neurotrophic factors, which were
able to induce neuritogenesis in PC12 cells in vitro and
protect brain from both hypoxic damage and glutamate
neurotoxicity [28–30]. Nonetheless, only selected molecules
have been dosed in ATSCs as possible neurotrophic can-
didates [28–31], while the expression of a wider panel of
neuro-speciﬁc molecules has not been assessed in ATSCs so
far.
The possible complete list of neurotrophic/neuroprotec-
tive factors speciﬁcally expressed by ATSC is proposed in
this study, as a result of the in silico analysis of diﬀerentially
expressed genes in MSC isolated from diﬀerent adult tissues
[3]. This revealed that ATSCs strongly and speciﬁcally
express at least three neurotrophins: NFGB, NRP1, and
FGF2. These secreted molecules reasonably represent the
molecular background of ATSC-neurotrophic features. The
in vitro assays in this study demonstrated that ATSCs could
in fact induce neurite outgrowth not only in PC12, but also
in human neuroblasts (LAN5 cell line). The induction of
neuronal diﬀerentiation should be the result of the demon-
strated presence of soluble secreted factors in ATSC culture
medium [28] along with cell-to-cell contacts with neural
cells in vitro. Thus, this event could be reasonably mediated
by both NGFB, which promotes neuronal diﬀerentiation
[9], and NRP1 that guides axon growth [15]. Also the
nonneurospeciﬁcgrowthfactorFGF2couldplayaroleinthis
event, being able to promote neurogenesis [22]. In addition,
theadhesionmoleculeCDH2thatisexpressedontheplasma
membrane and is involved in axonogenesis and synapse
assembly [19] could play a role in ATSC-mediated neuronal
diﬀerentiation of LAN-5 cells. Although, the possibility that
other factors participate in mediating this eﬀects cannot be
excluded.
Our data could also suggest that ATSCs neurotrophic
function resides in a sort of astrocyte-like phenotype, as they
speciﬁcally express genes belonging to the glial phenotype,
including VLDR, FGF2, and NDN, according to GOA
annotations. To this end, the necdin homolog (NDN) gene,
involved in the NGFB signalling pathway, is particularly
relevant, as it drives glial migration during nervous system
development and is expressed in the cell projections [23].
Although the neural transdiﬀerentiation capacity of MSCs
has been largely debated, many recent studies emphasise
the possibility of both bone marrow- and adipose tissue
derived-undiﬀerentiated stromal cells to diﬀerentiate along
the neuroectodermal lineage to neuronal-like cells of the
ectodermal lineage, mainly in vitro [32–42].
Recent data indeed assess the importance of cell-cell
interactions along with the release of growth factors from
the host tissue in ATSCs neural transdiﬀerentiation [43]. In
line with these observations, the results obtained in vivo,
followingcellimplantationintheneonatalratbrain,indicate
that ATSCs survive, migrate, and essentially diﬀerentiate
toward an astroglial fate. Taken together, our observations
suggest that ATSCs show a predisposition to the neural
fate as they express a molecular phenotype resembling
neural commitment in vitro and transdiﬀerentiate along the
neural lineage in vivo.
Recent reports evidence the successful implantation and
migration of ATSCs in vivo using experimental models of rat
brain ischemia, where they were able to promote functional
recovery [44–47]. In addition, diﬀerent groups reported
the neural transdiﬀerentiation of ATSCs transplanted in the
injured spinal cord [48, 49], evidencing that, when detached
from the physiological niche, they express ectoderm neural
markers [50]. We may speculate that secreted soluble factors
from neighbouring cells and physical reciprocal contacts
with neural cells may cause/facilitate transdiﬀerentiation
processes, as also indicated by the expression of the NGF
receptor TRKA by transplanted ATSCs. This evidence,
reported in in vitro studies [51], could suggest a possible
autocrine mechanism on ATSC, as they express NGFB in
vitro,althoughthefunctionalsigniﬁcanceofthisobservation
deserves further studies.
Taken together, the results obtained in this study seemed
to indicate that ATSC neurotrophic features reside in their
speciﬁc capability of expressing not only secreted neu-
rotrophins/neuroprotective molecules, but also structural
protein-coding genes, mimicking the astrocyte function in
sustaining neurons metabolism and function in the cen-
tral nervous system and being able to diﬀerentiate into
astrocytes. These properties, along with their reported
capacity to migrate in injured tissues, could suggest possible
future applications of ATSCs in many diverse neurological
contexts.8 Journal of Biomedicine and Biotechnology
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